CION Ameerpet
Gastrointestinal lymphoma starts in the wall of the stomach or intestine, not in a lymph node. This guide explains GI tract lymphoma symptoms, how it is diagnosed, and how CION's haematology team plans care.
Gastrointestinal (GI) lymphoma is a lymphoma that begins in the wall of the digestive tract rather than in a lymph node. Because it starts outside the lymph nodes, it is a form of extranodal lymphoma — in fact, the GI tract is the most common extranodal site of all. The stomach is by far the most frequent location, which is why so many people search for "stomach lymphoma", but intestinal lymphoma — in the small or large bowel — also occurs.
Almost all GI lymphomas are non-Hodgkin B-cell lymphomas. Two subtypes account for the majority: gastric MALT lymphoma, a slow-growing (indolent) marginal zone lymphoma closely tied to Helicobacter pylori infection, and diffuse large B-cell lymphoma (DLBCL), which is aggressive and fast-growing. Less commonly, mantle cell lymphoma, follicular lymphoma and Burkitt lymphoma can also involve the gut.
The single most useful thing to understand is that the exact subtype — confirmed on biopsy tissue — drives everything that follows. An indolent MALT lymphoma and an aggressive DLBCL both start in the stomach yet are treated in completely different ways. This guide explains the symptoms, the H. pylori link, how the disease is diagnosed and how it is treated. For the full picture, see our Lymphoma Treatment in Hyderabad page and the lymphoma hub.
The gastrointestinal tract is the most common site for extranodal non-Hodgkin lymphoma, and the stomach is the single most frequent organ involved. Most gastric lymphomas are one of two types — indolent MALT lymphoma or aggressive diffuse large B-cell lymphoma — and telling them apart on biopsy is essential because their treatments differ completely. (Source: NCCN and ESMO clinical practice guidelines on gastric and extranodal marginal zone / B-cell lymphomas.)
The symptoms of gastrointestinal lymphoma are often vague and closely resemble ordinary stomach and bowel complaints — which is exactly why the diagnosis can be delayed. Symptoms depend on where the lymphoma sits and how fast it grows. Common warning signs include:
Most of these symptoms have ordinary causes and are not lymphoma. But a symptom that is new, persistent and not settling — especially with weight loss or signs of bleeding — should be investigated with an endoscopy. Speak to a CION specialist if these signs persist or you have a confirmed GI lymphoma.
Different GI lymphomas behave very differently. Knowing the exact type — confirmed on tissue — is what lets the team tailor treatment precisely.
An indolent (slow-growing) marginal zone lymphoma of the stomach, usually driven by chronic H. pylori infection. Early, infection-positive cases can often be controlled — or cleared — simply by treating the bacteria. Read more on our MALT lymphoma page.
The most common aggressive GI lymphoma. It grows quickly and needs prompt treatment, but is often highly treatable. Learn more about DLBCL and its survival & prognosis.
Less commonly, mantle cell lymphoma can involve the bowel (sometimes as multiple polyps), and follicular lymphoma can arise in the small intestine. Both need subtype-specific plans.
High-grade types such as Burkitt lymphoma occasionally present in the intestine, often in younger patients, and require urgent, intensive treatment. Rare T-cell GI lymphomas also exist.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just received a stomach or intestinal lymphoma diagnosis, want to understand your subtype and H. pylori status, or need a second opinion before treatment? CION's haematology team is here.
One of the most striking facts in cancer medicine is that many gastric MALT lymphomas are caused by a treatable bacterial infection. Long-standing infection with Helicobacter pylori triggers chronic inflammation in the stomach lining. Over years, lymphoid tissue builds up in the stomach wall — tissue that would not normally be there — and a marginal zone lymphoma can develop within it.
The practical consequence is remarkable: in early-stage, H. pylori-positive gastric MALT lymphoma, clearing the infection with a short course of antibiotics and acid-suppressing therapy can lead the lymphoma itself to regress in a large proportion of patients. This is why NCCN and ESMO guidance recommend infection eradication as the first-line treatment for suitable cases, followed by careful endoscopic monitoring to confirm the lymphoma has cleared. It is one of very few cancers that can respond to treating an infection.
Not every case follows this path. Cases that do not respond, that lack the infection, or that have already transformed into an aggressive type need standard lymphoma treatment. That is why an accurate diagnosis — including H. pylori testing on the biopsy — comes first.
Diagnosing GI lymphoma — and pinning down the exact subtype and stage — follows a step-by-step pathway. CION coordinates biopsy, delivers pathology review, imaging and bone-marrow assessment directly.
An endoscopy — a thin camera passed into the stomach or bowel — lets the doctor see the lining and take biopsy samples of any abnormal areas. Only tissue examined by a pathologist can confirm the diagnosis. Immunohistochemistry identifies the exact subtype and tests markers such as CD20, which also guides whether an antibody therapy will help. On gastric samples, H. pylori is tested for at the same time.
Once lymphoma is confirmed, a PET-CT or CT scan maps how far it extends — whether it is confined to the stomach or bowel wall, or involves nearby lymph nodes and other organs. A bone-marrow examination is often done to complete staging. Blood tests round out the picture.
At CION, every gastrointestinal lymphoma is discussed by a multidisciplinary tumour board — haematology, medical oncology, radiation oncology and pathology together — before the treatment plan is finalised, in line with NCCN and ESMO guidance. This is especially important here, because the same starting point can mean an indolent MALT lymphoma or an aggressive DLBCL.
In early-stage gastric MALT lymphoma that tests positive for Helicobacter pylori, treating the infection with antibiotics alone can lead the lymphoma to regress in a large majority of patients — which is why NCCN and ESMO recommend infection eradication as first-line therapy for suitable cases, followed by close endoscopic monitoring. It is one of the few cancers where treating an infection can treat the disease.
The plan depends on the subtype, site, stage and your overall health. Every case is reviewed by CION's tumour board before treatment begins. The main building blocks are:
For early-stage, H. pylori-positive gastric MALT lymphoma, the first step is usually a course of antibiotics and acid-suppressing therapy to clear the infection, followed by endoscopic monitoring. Many of these lymphomas regress once the bacteria are gone.
For aggressive types such as DLBCL, or MALT lymphoma that does not respond to infection treatment, therapy is typically drug-based. Because these are usually CD20-positive B-cell lymphomas, an anti-CD20 monoclonal antibody is often combined with chemotherapy. CION delivers both directly. We describe treatment by drug class here; specific regimen names are individualised on our Lymphoma Treatment in Hyderabad page.
For some localised gastric MALT lymphomas — particularly H. pylori-negative cases or those that do not respond to antibiotics — involved-site radiation therapy can be very effective. CION delivers precision radiation (IMRT) directly, shaping the beam to the affected area.
Unlike stomach adenocarcinoma, GI lymphoma is usually not treated by removing the stomach or bowel. Surgery is reserved mainly for complications such as significant bleeding, perforation or obstruction. For more advanced or relapsed disease, options including a stem-cell transplant may be considered — this is coordinated through accredited partner facilities when appropriate, not delivered in-house. See our note on relapsed or refractory DLBCL.
The outlook depends heavily on the subtype and stage. Gastric MALT lymphoma is typically indolent and carries an excellent long-term outlook — many early, H. pylori-driven cases are controlled or cleared. Aggressive GI lymphomas such as DLBCL grow faster but are often highly treatable; published series report broadly 60–70% survival for DLBCL overall, though GI-specific and individual outcomes vary. For comparison, Hodgkin lymphoma survival is often quoted at around 80–90% in published data.
These are published, attributed figures from clinical series (as summarised by NCCN and ESMO) and vary considerably by individual — age, stage, subtype and general health all matter, and no single number predicts one person's journey. CION does not make one-size-fits-all promises; your own outlook is best discussed with your oncologist. For living well with slow-growing disease, see living with an indolent lymphoma.
A stomach or intestinal lymphoma diagnosis carries a lot of nuance, and a second opinion is especially valuable in a few situations:
CION offers a dedicated, free written second-opinion service. You can also explore our best lymphoma doctors in Hyderabad and best lymphoma hospital in Hyderabad. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if your subtype or H. pylori status has not yet been clarified.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Gastrointestinal (GI) lymphoma is a lymphoma that starts in the wall of the digestive tract rather than in a lymph node — a form of extranodal lymphoma. The stomach is the single most common site, which is why "stomach lymphoma" is the term many people search for, but it can also arise in the small or large intestine. Most cases are non-Hodgkin B-cell lymphomas. Two types dominate: MALT lymphoma, a slow-growing marginal zone lymphoma often linked to Helicobacter pylori infection, and diffuse large B-cell lymphoma (DLBCL), which is aggressive. Getting the exact subtype confirmed on biopsy tissue is what shapes the whole treatment plan.
GI tract lymphoma symptoms are often vague and easily mistaken for common stomach problems, which is why diagnosis can be delayed. Typical signs include persistent upper-abdominal pain or discomfort, indigestion that does not settle, feeling full quickly, nausea, and unintended weight loss. Some people notice abdominal fullness or swelling as nodes or the spleen enlarge, or have signs of slow bleeding such as tiredness from anaemia or dark stools. Intestinal lymphoma can rarely present with a blockage. Classic "B symptoms" — drenching night sweats, unexplained fevers and marked weight loss — can also occur. Any of these lasting more than a few weeks deserves review. Speak to a CION specialist if symptoms persist.
Most gastric MALT lymphomas are driven by long-standing Helicobacter pylori infection. The chronic inflammation from this stomach bacterium causes lymphoid tissue to build up in the stomach wall, and over years a marginal zone lymphoma can develop within it. The remarkable consequence is that in early-stage, H. pylori-positive gastric MALT lymphoma, clearing the infection with a course of antibiotics and acid-suppressing therapy can lead the lymphoma to regress in a large proportion of patients — a rare example of treating cancer by treating an infection. This is recommended first-line in NCCN and ESMO guidance for suitable cases, followed by close endoscopic monitoring. Cases that do not respond, or that lack the infection, are treated differently.
Diagnosis begins with an endoscopy — a camera passed into the stomach or bowel — during which the doctor takes biopsy samples of any abnormal areas. A pathologist examines the tissue and runs immunohistochemistry to confirm it is lymphoma, identify the exact subtype, and test markers such as CD20. Testing for H. pylori is done on gastric samples. Staging then uses a PET-CT or CT scan and often a bone-marrow examination to map how far the disease extends. CION delivers biopsy coordination, endoscopic pathology review, imaging and bone-marrow assessment directly, and every case is discussed at a multidisciplinary tumour board before a plan is set. See our lymphoma treatment page for the full workup.
No — although both start in the stomach, they are different diseases. The far more common "stomach cancer" (gastric adenocarcinoma) begins in the gland cells that line the stomach. Stomach lymphoma begins in immune (lymphoid) cells within the stomach wall and is a type of lymphoma, not a carcinoma. This distinction matters enormously, because the treatments are completely different: many gastric lymphomas respond to antibiotics (for H. pylori-driven MALT), immunotherapy and chemotherapy, and often do not need the stomach to be surgically removed, whereas adenocarcinoma is usually treated with surgery. Only a biopsy examined by a pathologist can tell the two apart — which is why tissue diagnosis before any treatment is essential.
Treatment depends on the subtype, site and stage. Early H. pylori-positive gastric MALT lymphoma is often treated first with antibiotics to clear the infection, with endoscopic monitoring afterwards. When that is not enough, or for aggressive types such as DLBCL, options include an anti-CD20 monoclonal antibody, chemotherapy, and involved-site radiation therapy (IMRT) — all delivered directly by CION. Surgery is used selectively, mainly for complications such as bleeding or obstruction rather than as the main treatment. Every plan follows NCCN and ESMO guidance and is set by a tumour board. Specific regimen names are individualised — see our Lymphoma Treatment in Hyderabad page.
The outlook depends heavily on the subtype and stage. Gastric MALT lymphoma is typically slow-growing (indolent) and has an excellent long-term outlook — many early cases are controlled or cleared, especially when linked to H. pylori. Aggressive GI lymphomas such as DLBCL grow faster but are often highly treatable, with published series reporting broadly 60–70% survival for DLBCL overall, though GI-specific outcomes vary. These figures come from published studies and vary considerably by individual — age, stage, subtype and general health all matter. Your own outlook is best discussed with your oncologist. CION avoids one-size-fits-all promises and gives you an honest, evidence-led picture. Read more on DLBCL prognosis.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.